Improve Quality of Care and Bed Utilization

Earlier Discharge or Stepdown

Fast antimicrobial susceptibility test (AST) results from the Accelerate Pheno® system can help clinicians reduce length of stay (LOS) for patients with bacteremia — a leading cause of sepsis — by 2 days or more.

And during a crisis like the COVID-19 pandemic, the sooner patients are discharged or stepped down, the sooner their beds are free for other patients.

For example, fast results from the Accelerate Pheno® system have helped the University of Arkansas for Medical Sciences reduce inpatient LOS for bacteremic inpatients by 2.4 days.

See below how these LOS reductions can help hospitals manage beds more efficiently for the patients who need them most.

Let’s talk about the potential impact at your hospital:

Length of Stay Reductions

Bed Utilization

Fast Results for Clinical Optimization

Clinical microbiology laboratories at hospitals across the United States are using the Accelerate Pheno system to cut the wait time for antimicrobial susceptibility test (AST) results by approximately 40 hours.

Antimicrobial stewardship teams are using these expedited phenotypic AST results to support faster and better decision-making around antibiotic therapy recommendations.

Earlier clinical optimization with faster microbiology results from the Accelerate Pheno system provides multiple benefits in addition to LOS reductions:

  • ID in ~2 hours, AST in ~7 hours
  • Expedited results reporting4
  • Timely therapy optimization2,5,6 (escalation and de-escalation)
  • Reduced antibiotic days on therapy1,2,3

See the test